ESLHO EQA program

At ESLHO, we are dedicated to elevating standards in diagnostic testing by providing external quality assessments (EQA) to laboratories worldwide. These assessments are offered through the ESLHO EQA Program, which includes a range of EQA schemes across the hemato-oncology and immunology fields. Our primary goal is to ensure accuracy and reliability in diagnostic results. By using solid evaluation processes and offering clear, practical educational support, we help laboratory professionals strengthen their diagnostic skills and deepen their understanding of best practices. This combination of assessment and education boosts laboratory performance and contributes to better patient outcomes.

The EQA schemes are organized by ESLHO in collaboration with subject-matter experts from laboratories within the EuroClonality, EuroFlow, and EuroMRD consortia, who perform relevant diagnostic analyses on a routine basis. The schemes cover diagnostic and monitoring workflows and include immunoglobulin/T-cell receptor (IG/TR) clonality testing, multiparameter flow-cytometry panels (for example, in primary immunodeficiencies, leukemias, and multiple myeloma), and measurable residual disease (MRD) detection using RQ-PCR, dPCR, and NGS. The involvement of these expert laboratories is invaluable because of their high-level expertise and access to high-quality samples and clinical cases, ensuring that the EQA schemes are clinically relevant and of consistently high quality.

We offer the EQA Program through the ESLHO EQA Portal. On this website, you can view the available schemes and find detailed scheme information including costs, timelines, and involved expert laboratories. After creating an account, you can manage schemes from registration to report, including downloading scheme instructions and case files (if applicable), submission of EQA results, and accessing participation certificates and reports.

For more information or to register for EQA schemes, please visit the ESLHO EQA Portal.